Skip to content
Clinical Treatment Scenarios: Vitiligo Pathogenesis and the Role of JAK Inhibition –
In the Clinic
Evaluation (ID: i873-7)
*
1.
Which of the following best describes your profession?
(Required.)
MD/DO
PA
NP
RN
Other (please specify)
*
2.
Which of the following best describes your specialty?
(Required.)
Dermatology
Internal Medicine/Family Medicine/General Practice
Pediatrics
Other (please specify)
*
3.
How many patients with vitiligo do you see in a typical month?
(Required.)
1 to 10
11 to 25
26 to 50
More than 50
0
*
4.
How many years have you been in practice?
(Required.)
<1
1 to 10
11 to 20
>20
*
5.
Which of the following best describes your practice setting?
(Required.)
Academic medical center
Community hospital
Group practice
Private practice
VA/DOD/Government
Other (please specify)
*
6.
After participating in this activity, how confident are you in the management of patients with vitiligo in your practice?
(Required.)
Very confident
Confident
Little confidence
No confidence
*
7.
Please rate your level of agreement by checking the appropriate rating. The educational activity:
(Required.)
Strongly agree
Agree
Disagree
Strongly disagree
Met the stated learning objectives
Strongly agree
Agree
Disagree
Strongly disagree
Enhanced my current knowledge base
Strongly agree
Agree
Disagree
Strongly disagree
Addressed my most pressing questions
Strongly agree
Agree
Disagree
Strongly disagree
Promoted improvements or quality in health care
Strongly agree
Agree
Disagree
Strongly disagree
Was scientifically rigorous and evidence based
Strongly agree
Agree
Disagree
Strongly disagree
Was effectively delivered by faculty
Strongly agree
Agree
Disagree
Strongly disagree
Avoided commercial bias or influence
Strongly agree
Agree
Disagree
Strongly disagree
*
8.
Which of the following best describes the impact of this activity on your performance?
(Required.)
I gained new strategies/skills/information I will apply to my area of practice
I need more information before I can change my practice
My practice is already consistent with the information presented
This activity will not change my practice
*
9.
How committed are you to making changes in your practice based on your participation in this activity?
(Required.)
Very committed
Committed
Not committed
I do not plan to make changes
If not committed or do not plan to make changes, please indicate reason.
*
10.
Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.
(Required.)
Look for signs that show if vitiligo is stable or spreading
Seek additional information about the pathogenesis of nonsegmental vitiligo
Seek more information about the JAK/STAT pathway in vitiligo
Consider treatment options that address the Th1 underlying pathogenesis of vitiligo
Ask patients with vitiligo about their interest in trying ruxolitinib cream
Advise patients about body parts that are likely to respond most rapidly and most slowly to ruxolitinib cream treatment
Seek more information about emerging agents for the treatment of vitiligo
Other (please specify)
*
11.
What barriers do you see to making changes in your practice? Please select all that apply.
(Required.)
Lack of knowledge regarding evidence-based strategies
Lack of convincing evidence to warrant change
Lack of time/resources to consider change
Insurance, reimbursement, or legal issues
Conflicting guidelines or evidence
Patient compliance and/or patient resource barriers
Other (please specify)
12.
As a result of your participation in this activity, what is one change you are most likely to implement in your practice?
13.
Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for vitiligo:
14.
If you indicated that you perceived commercial bias or influence, please describe: